Neurokinin receptor mRNA localization in human midbrain dopamine neurons

Journal of Comparative Neurology

Volumn 382, Issue 3, 1997, Pages 394-400

  Whitty, Christopher J ^a   Paul, Michael A ^a   Bannon, Michael J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

In situ hybridization; Substance P; Substantia nigra; Tachykinin; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROKININ A; SUBSTANCE P;

ADOLESCENT; ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; DOPAMINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MESENCEPHALON; MIDDLE AGED; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RECEPTORS, TACHYKININ; RNA, MESSENGER;

EID: 0030927916     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19970609)382:3<394::AID-CNE6>3.0.CO;2-Z     Document Type: Article

References (35)

1. Bannon, M.J., and C.J. Whitty (1995) Neurokinin receptor gene expression in substantia nigra: Localization, regulation and potential physiological significance. Can. J. Physiol. Pharmacol. 73:866-870.
2. Bannon, M.J., and C.J. Whitty (1997) Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology 48:160-168.
3. Bannon, M.J., C.H. Xue, K. Shibata, L.J. Dragovic, and G. Kapatos (1990) Expression of a human cocaine-sensitive dopamine transporter in Xenopus laevis oocytes. J. Neurochem. 54:706-708.
4. Bannon, M.J., L.A. Brownschidle, Y. Tian, C.J. Whitty, M.S. Poosch, C. D'sa, and C.A. Moody (1995) Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamine. Brain Res. 695:19-24.
5. Beach, T.G., and E.G. McGeer (1984) The distribution of substance P in the primate basal ganglia: An immunohistochemical study of baboon and human brain. Neuroscience 13:29-52.
6. Bouras, C., P.G. Vallet, H. Dobrinov, S. de St.-Hilaire, and J. Constantinidis (1986) Substance P neuronal cell bodies in the human brain: Complete mapping by immunohistofluorescence. Neurosci. Lett. 68:31-36.
7. Brodin, E., N. Lindefors, C.J. Dalsgaard, E. Theodorsson-Norheim, and S. Rosell (1986) Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. Regul. Pept. 13:253-272.
8. Buck, S.H., C.J. Heike, E. Burcher, C.W. Shults, and T. O'Donohue (1986) Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides 7:1109-1120.
9. Buell, G., M.F. Schulz, S.J. Arkinstall, K. Maury, M. Missotten, N. Adami, F. Talabot, and E. Kawashima (1992) Molecular characterization, expression and localization of human neurokinin-3 receptor. FEBS Lett. 299:90-95.
10. Chang, H.T. (1988) Substance P-dopamine relationship in the rat substantia nigra: A light and electron microscopy study of double immunocytochemically labeled materials. Brain Res. 448:391-396.
11. DeArmond, S.J., M.M. Fusco, and M.M. Dewey (1989) A Photographic Atlas of the Human Brain. New York: Oxford University Press, pp. 110-115.
12. Dietl, M.M., and J.M. Palacios (1991) Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: Apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain. Brain Res. 539:211-222.
13. Fernandez, A., M.L. De Ceballos, P. Jenner, and C.D. Marsden (1994) Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of parkinson's disease patients. Neuroscience 61:73-79.
14. Haber, S. N., and H.J. Groenewegen (1989) Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia nigra. J. Comp. Neurol. 290:53-68.
15. 2 receptor, tyrosine hydroxylase and calbindin immunoreactivity. J. Comp. Neurol. 362:400-410.
16. Halliday, G.M., and I. Tork (1986) Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human. J. Comp. Neurol. 252:423-445.
17. Helke, C.J., J.E. Krause, P.W. Mantyh, R. Couture, and M.J. Bannon (1990) Diversity in mammalian tachykinin peptidergic neurons: Multiple peptides, receptors, and regulatory mechanisms. FASEB J. 4:1606-1615.
18. 2 receptor messenger RNAs are differentially expressed in limbic-and motor-related subpopulations of human mesencephalic neurons. Neuroscience 63:357-362.
19. Inagaki, S., and A. Parent (1984) Distribution of substance P and enkephalin-like immunoreactivity in the substantia nigra of rat, cat and monkey. Brain Res. Bull. 13:319-329.
20. Kanazawa, I., P.C. Emson, and A.C. Cuello (1977) Evidence for the existence of substance P-containing fibres in striato-nigral and pallidonigral pathways in rat brain. Brain Res. 119:447-453.
21. Kanazawa, I., T. Ogawa, S. Kimura, and E. Munekata (1984) Regional distribution of substance P, neurokinin a, and neurokinin b in rat central nervous system. Neurosci. Res. 2:111-120.
22. Kastner, A., E.C. Hirsch, O. Lejeune, F. Javoy-Agid, O. Rascol, and Y. Agid (1992) Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J. Neurochem. 59:1080-1089.
23. Kawai, Y., H. Tagaki, Y. Kumoi, S. Shiosaka, and M. Tohyama (1987) Nigrostriatal dopamine neurons receive substance P-ergic inputs in the substantia nigra: Application to the immunoelectron microscope mirror technique to fluorescent double-staining for transmitter-specific projections. Brain Res. 401:371-376.
24. Kish, S.J., K. Shannak, A. Rajput, J.H.N. Deck, and O. Hornykiewicz (1992) Aging produces a specific pattern of striatal dopamine loss: Implications for the etiology of idiopathic Parkinson's disease. J. Neurochem. 58:642-648.
25. Kowall, N.W., B.J. Quigley, J.E. Krause, F. Lu, B.E. Korofsky, and R.J. Ferrante (1993) Substance P and substance P receptor histochemistry in human neurodegenerative diseases. Regul. Peptides 46:174-185.
26. Maeno, H., H. Kiyama, and M. Tohyama (1993) Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Mol. Brain Res. 18:43-58.
27. Mantyh, P.W., T. Gates, C.R. Mantyh, and J.E. Maggio (1989) Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J. Neurosci. 9:258-279.
28. 125I-Bolton Hunter substance P binding sites in human brain. Neurochem. Int. 18:399-404.
29. Rothman, R.B., M. Herkenham, C.B. Pert, T. Liang, and A. Casciere (1984) Visualization of rat brain receptors for the neuropeptide, substance P. Brain Res. 309:47-54.
30. 3 ligands) in the rat brain. Peptides 9:227-241.
31. Shults, C.W., R. Quirion, B. Chronwall, T.N. Chase, and T.L. O'Donohue (1984) A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides 5:1097-1128.
32. Sivam, S.P., and J.E. Krause (1992) Tachykinin systems in the spinal cord and basal ganglia: Influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA. J Neurochem. 59:2278-2284.
33. Stoessl, A.J. (1994) Localization of striatal and nigral tachykinin receptors in the rat. Brain Res. 646:13-18.
34. Tenovuo, O., O. Kolhinen, A. Laihinen, and U.K. Rinne (1990) Brain substance P receptors in Parkinson's disease. Adv. Neurol. 53:145-148.
35. Whitty, C.J., P.D. Walker, D.J. Goebel, M.S. Poosch, and M.J. Bannon (1995) Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra. Neuroscience 64:419-425.